D.E. Shaw & Co
NUTX

D.E. Shaw & Co’s Nutex Health NUTX Stock Holding History

D.E. Shaw & Co’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.7M Buy
+97,454
New +$12.3M 0.01% 1422
2023
Q3 		– Sell
-3,736
Closed -$236K – 4414
2023
Q2 		$236K Buy
+3,736
New +$320K ﹤0.01% 3686
2022
Q3 		– Sell
-292
Closed -$141K – 5418
2022
Q2 		$141K Buy
+292
New +$344K ﹤0.01% 4662

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

D.E. Shaw & Co's NUTX Position: Q2 2026 in Review

D.E. Shaw & Co opened a new position in Nutex Health (NUTX) in Q2 2026: 97,454 shares worth $16.7M. The stake represents 0.01% of the portfolio and ranks #1422 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in NUTX as recently as Q2 2023.

D.E. Shaw & Co first reported a position in NUTX in Q2 2022 and has held it in 3 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • D.E. Shaw & Co held 97,454 shares of Nutex Health worth $16.7M as of Q2 2026.
  • Nutex Health was a new D.E. Shaw & Co position in Q2 2026.
  • Nutex Health made up 0.01% of D.E. Shaw & Co's portfolio in Q2 2026, its #1422 holding.
  • D.E. Shaw & Co first reported a position in Nutex Health in Q2 2022 and has held it in 3 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.